Series:

VJCRGS: Vol. 32 |  Issue 2

Vol. 32 |  Issue 2

Vol. 32,  Issue 2

Omidria

Show Description +

Robert Osher, MD, discusses the use of Omidria (Omeros) in cataract surgery and shows several cases with and without the agent for comparison. The medication is a combination of ketorolac, which blocks the miotic response to the release of prostaglandins during phaco, and phenylephrine, which constantly stimulates the pupillary dilator.

Posted: 9/06/2016

Up Next in this Program


Iris Hooks

Thomas A. Oetting, MD

APX

Ehud Assia, MD

B-Hex Pupil Expander

Dr. Suven Bhattacharjee

Morcher Pupil Expander

Howard Fine, MD

Cana's Ring

Sergio Canabrava, MD

Surgical Miosis: History

Robert Osher, MD

Modified Locking Siepser Knot

Michael Snyder, MD

Modified Siepser Knot

Garry Condon, MD

Cerclage in America

Greg Ogawa, MD

Cerclage in Russia

Marina Shanturova, MD

Cerclage Gone Awry

Michael Snyder, MD

IFIS

Pooja Garg, MD and John Hart, Jr., MD

Leukocoria: Novel Solution

Robert Osher, MD

Conclusion

Robert Osher, MD

Vol. 32,  Issue 2

Omidria

Robert Osher, MD, discusses the use of Omidria (Omeros) in cataract surgery and shows several cases with and without the agent for comparison. The medication is a combination of ketorolac, which blocks the miotic response to the release of prostaglandins during phaco, and phenylephrine, which constantly stimulates the pupillary dilator.

Posted: 9/06/2016


Please log in to leave a comment.